Achromatopsia Clinical Trials 2022

Browse 6 Achromatopsia Medical Studies Across 14 Cities

24 Achromatopsia Clinics

Reviewed by Michael Gill, B. Sc.
6 Achromatopsia Clinical Trials Near Me
San Antonio, TX
New York, NY
Atlanta, GA
Ann Arbor, MI
More Trial Locations
An interactive map to display trial locations for University of the Incarnate Word Rosenberg School of Optometry, Edward S. Harkness Eye Institute, Emory Hospital, Kellog Eye Center, and 11 more locations.
Most Popular References for Achromatopsia Clinical Trials
Frequency
Citation
Top Hospitals for Achromatopsia Clinical Trials
Location
Active Achromatopsia Clinical Trials
All Time Trials for Achromatopsia
First Recorded Achromatopsia Trial
Trials
Casey Eye Institute, Oregon Health and Sciences University, Portland, Oregon
2
2
2016
Boston Children's Hospital, Boston, Massachusetts
2
2
2016
Baylor College of Medicine, Houston, Texas
2
2
2016
University of California, San Francisco, San Francisco, California
2
2
2016
Massachusetts Eye and Ear Infirmary, Boston, Massachusetts
2
2
2016
Top Treatments for Achromatopsia Clinical Trials
Treatment Name
Active Achromatopsia Clinical Trials
All Time Trials for Achromatopsia
First Recorded Achromatopsia Trial
Trials
Experimental Group 1: Color Correcting Lenses
1
1
2022
either AAV - CNGB3 or AAV - CNGA3
1
1
2017
Top Cities for Achromatopsia Clinical Trials
City
Active Achromatopsia Clinical Trials
Top Active Site for Achromatopsia Clinical Trials
Trial List
Boston, Massachusetts
4
Boston Children's Hospital
Portland, Oregon
2
Casey Eye Institute, Oregon Health and Sciences University
San Francisco, California
2
University of California, San Francisco
Which phases are most popular for achromatopsia clinical trials?
Most Recent Achromatopsia Clinical Trials
Pediatric Achromatopsia Clinical Trials
Clinical Trial
Began Recruiting Date
Phase
8/3/2017
Phase 1 & 2
Senior Friendly Achromatopsia Clinical Trials

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 6th, 2021

Last Reviewed: August 19th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.